In vivo imaging of graftversus-host disease and graftversus-leukemia - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 76

[9] Hastings JW, McElroy EW, Coulombre J. The effect of oxygen upon the immobilization
reaction in firefly luminescence. J Cell Physiol 1953;42:137-50.
[10] Hastings JW, Gibson QH. The role of oxygen in the photoexcited luminescence of bac-
terial luciferase. J Biol Chem 1967;242:720-6.
[11] Lorenz WW, McCann RO, Longiaru M, Cormier MJ. Isolation and expression of a cDNA
encoding Renilla reniformis luciferase. Proc Natl Acad Sci USA 1991;88:4438-42.
[12] Mezzanotte L, Fazzina R, Michelini E, et al. In vivo bioluminescence imaging of murine
xenograft cancer models with a red-shifted thermostable luciferase. Mol Imaging Biol
2010;12:406-14.
[13] Contag CH, Jenkins D, Contag PR, Negrin RS. Use of reporter genes for optical measure-
ments of neoplastic disease in vivo . Neoplasia 2000;2:41-52.
[14] Cui K, Xu X, Zhao H, Wong ST. A quantitative study of factors affecting in vivo biolumi-
nescence imaging. Luminescence 2008;23:292-5.
[15] Zhao H, Doyle TC, Wong RJ, et al. Characterization of coelenterazine analogs for
measurements of Renilla luciferase activity in live cells and living animals. Mol Imaging
2004;3:43-54.
[16] Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression
in living mice. Proc Natl Acad Sci USA 2002;99:377-82.
[17] Contag CH. In vivo pathology: seeing with molecular specificity and cellular resolution
in the living body. Annu Rev Pathol 2007;2:277-305.
[18] De A, Yaghoubi SS, Gambhir SS. Applications of lentiviral vectors in noninvasive mo-
lecular imaging. Methods Mol Biol 2008;433:177-202.
[19] Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors
for gene therapy. Nat Rev Genet 2003;4:346-58.
[20] Cao YA, Wagers AJ, Beilhack A, et al. Shifting foci of hematopoiesis during reconstitu-
tion from single stem cells. Proc Natl Acad Sci USA 2004;101:221-6.
[21] Negrin RS, Contag CH. In vivo imaging using bioluminescence: a tool for probing graft-
versus-host disease. Nat Rev Immunol 2006;6:484-90.
[22] Jobsis FF. Noninvasive, infrared monitoring of cerebral and myocardial oxygen suf-
ficiency and circulatory parameters. Science 1977;198:1264-7.
[23] Beilhack A, Schulz S, Baker J, et al. In vivo analyses of early events in acute graft-versus-
host disease reveal sequential infiltration of T-cell subsets. Blood 2005;106:1113-22.
[24] Murai M, Yoneyama H, Ezaki T, et al. Peyer's patch is the essential site in initiating
murine acute and lethal graft-versus-host reaction. Nat Immunol 2003;4:154-60.
[25] Mora JR, Bono MR, Manjunath N, et al. Selective imprinting of gut-homing T cells by
Peyer's patch dendritic cells. Nature 2003;424:88-93.
[26] Beilhack A, Schulz S, Baker J, et al. Prevention of acute graft-versus-host disease by
blocking T-cell entry to secondary lymphoid organs. Blood 2008;111:2919-28.
[27] Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Curr
Opin Immunol 1993;5:794-9.
[28] Krenger W, Hill GR, Ferrara JL. Cytokine cascades in acute graft-versus-host disease.
Transplantation 1997;64:553-8.
[29] Via CS, Rus V, Gately MK, Finkelman FD. IL-12 stimulates the development of acute
graft-versus-host disease in mice that normally would develop chronic, autoimmune
graft-versus-host disease. J Immunol 1994;153:4040-7.
[30] Williamson E, Garside P, Bradley JA, Mowat AM. IL-12 is a central mediator of acute
graft-versus-host disease in mice. J Immunol 1996;157:689-99.
[31] Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS.
In vitro -differentiated TH17 cells mediate lethal acute graft-versus-host dis-
ease with severe cutaneous and pulmonary pathologic manifestations. Blood
2009;113:1365-74.
[32] Iclozan C, Yu Y, Liu C, et al. T helper17 cells are sufficient but not necessary to induce
acute graft-versus-host disease. Biol Blood Marrow Transplant 2010;16:170-8.
[33] Li X, Deng R, He W, et al. Loss of B7-H1 expression by recipient parenchymal cells leads
to expansion of infiltrating donor CD8 + T cells and persistence of graft-versus-host
disease. J Immunol 2012;188:724-34.
[34] Agata Y, Kawasaki A, Nishimura H, et al. Expression of the PD-1 antigen on the surface
of stimulated mouse T and B lymphocytes. Int Immunol 1996;8:765-72.
[35] Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immu-
nity. Nat Rev Immunol 2004;4:336-47.
[36] Schoop R, Wahl P, Le Hir M, Heemann U, Wang M, Wuthrich RP. Suppressed T-cell ac-
tivation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells.
Nephrol Dial Transplant 2004;19:2713-20.
[37] Nakazawa A, Dotan I, Brimnes J, et al. The expression and function of costimulatory mol-
ecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology 2004;126:1347-57.

77